New NIH grants fuel research in oral cancer treatment and pain relief
Researchers at the School of Dentistry at UT Health San Antonio, the academic health center of The University…
TROP2 identified as a promising therapeutic target for renal medullary carcinoma
Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and…
Study reports the world’s first genetically engineered pig-to-human liver xenotransplantation
An important new study in the Journal of Hepatology, published by Elsevier, reports the world’s first auxiliary liver…
Next-generation imaging promises sharper, deeper view of living tissues
A University of Arizona research team will receive nearly $2.7 million from the NIH’s Common Fund Venture Program to advance next-generation…
Genetic risk score can help identify women at higher risk of invasive breast cancer
Studying a person’s genetic makeup can predict if they will go on to develop invasive breast cancer after…
Radiomics significantly outperforms clinical models for predicting NPC treatment outcome
Nasopharyngeal carcinoma (NPC) is a highly aggressive malignancy, with most patients presenting at locally advanced stages. While immune…
Study identifies key molecular and clinical biomarkers for MASLD
Background and aims The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain…
Molecular breast imaging increases overall invasive cancer detection in women with dense breasts
Screening women with dense breasts with both molecular breast imaging (MBI) and digital breast tomosynthesis (DBT) increased overall…
Deep learning tool improves accuracy of lung nodule malignancy detection
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer…
Is Contrast-Free MRI the Optimal Test for PC?
A twist on magnetic resonance imaging that does not require gadolinium contrast appears to be as effective as…
Can CRISPR Help NK Cells Fight Cancer?
TOPLINE: Genome-wide CRISPR screens in primary human natural killer (NK) cells identified critical checkpoints regulating resistance to immunosuppressive…
ATOX1 drives hepatocellular carcinoma progression through c-Myb and PI3K/AKT activation
Background and aims Despite advancements in diagnostic and therapeutic strategies, hepatocellular carcinoma (HCC) remains a leading cause of…